Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Etoposide × Dermatologic × Clear all

Phase

Status

Completed 13 Terminated 5 Withdrawn 2 Active not recruiting 2 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 17 Sarcoma 2 Other solid neoplasm 1 Other hematologic neoplasm 1 Lymphoid 1 Head & Neck 1 Gynecologic 1 Gastrointestinal 1 Dermatologic 1

Conditions

Carcinoma, Merkel Cell 1

Interventions

pembrolizumab 2 Standard of Care 2 Photochemotherapy 2 Nivolumab 2 Melphalan 2 Interleukin-2 2 Fluorouracil 2 Dermoscopy 2 Cryotherapy 2 trametinib 1 toripalimab 1 tirbanibulin 1 sulforaphane 1 secukinumab 1 relatlimab 1 encorafenib 1 decitabine and cedazuridine drug combination 1 daromun 1 cemiplimab 1 calcipotriene 1 binimetinib 1 anlotinib 1 Watchful Waiting 1 Vitamin D 1 Toll-Like Receptor 1 1 Therapeutics 1 Surveys and Questionnaires 1 Sunscreening Agents 1 Specimen Handling 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06086288 2023-10-17

PANDORA

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Not yet recruiting

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡